Also, in vitro data in other tumor entities such as prostate, gastric and hepatocellular cancer found FBP1 gene silencing, leading to promotion of epithelial to mesenchymal transition, invasion, and metastasis (He et al. 2021; Li et al. 2016; Li et al. 2020). This evidence concerns the gene FBP1 and neoplasm.